Sarepta Therapeutics (SRPT) Shares Outstanding (Weighted Average) (2010 - 2026)

Sarepta Therapeutics' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $105.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 7.83% year-over-year to $105.0 million; the TTM figure through Mar 2026 stood at $105.0 million (up 7.83% YoY), while the FY2025 annual figure was $100.1 million, up 5.31% from the prior year.
• Shares Outstanding (Weighted Average) was $105.0 million for Q1 2026 at Sarepta Therapeutics, up from $100.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $105.0 million in Q1 2026 to a low of $87253.0 in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $88.1 million across 5 years, with a median of $94.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) jumped 109837.06% in 2022, then rose 1.09% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $87.6 million in 2022, then rose by 5.53% to $92.4 million in 2023, then grew by 2.9% to $95.1 million in 2024, then gained by 5.31% to $100.1 million in 2025, then climbed by 4.86% to $105.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $105.0 million (Q1 2026), $100.1 million (Q4 2025), and $98.5 million (Q3 2025), per Business Quant data.